PT1558263E - Composicao farmaceutica de libertacao prolongada - Google Patents

Composicao farmaceutica de libertacao prolongada

Info

Publication number
PT1558263E
PT1558263E PT03772240T PT03772240T PT1558263E PT 1558263 E PT1558263 E PT 1558263E PT 03772240 T PT03772240 T PT 03772240T PT 03772240 T PT03772240 T PT 03772240T PT 1558263 E PT1558263 E PT 1558263E
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
prolonged liberation
liberation
prolonged
pharmaceutical
Prior art date
Application number
PT03772240T
Other languages
English (en)
Inventor
Schmid Peter
Boettner Alexander
Schmidt Carsten
Allan Mark
Barbot Carole
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PT1558263E publication Critical patent/PT1558263E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT03772240T 2002-10-25 2003-10-20 Composicao farmaceutica de libertacao prolongada PT1558263E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02079477 2002-10-25

Publications (1)

Publication Number Publication Date
PT1558263E true PT1558263E (pt) 2006-10-31

Family

ID=32116298

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03772240T PT1558263E (pt) 2002-10-25 2003-10-20 Composicao farmaceutica de libertacao prolongada

Country Status (18)

Country Link
EP (1) EP1558263B1 (pt)
JP (1) JP4584715B2 (pt)
CN (1) CN1326526C (pt)
AR (1) AR041713A1 (pt)
AT (1) ATE327759T1 (pt)
AU (1) AU2003279302B2 (pt)
BR (2) BR0315513A (pt)
CA (1) CA2501395C (pt)
CO (1) CO5700769A2 (pt)
DE (1) DE60305728T2 (pt)
ES (1) ES2265590T3 (pt)
MX (1) MXPA05004219A (pt)
NO (1) NO334158B1 (pt)
NZ (1) NZ539478A (pt)
PL (1) PL208585B1 (pt)
PT (1) PT1558263E (pt)
WO (1) WO2004037265A1 (pt)
ZA (1) ZA200502956B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007291308A1 (en) * 2006-08-30 2008-03-06 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
WO2009129101A1 (en) 2008-04-14 2009-10-22 Advanced Technologies And Regenerative Medicine, Llc Liquid buffered gdf-5 formulations
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
WO2012095438A1 (en) * 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
AU2012206621B2 (en) * 2011-01-12 2017-04-27 Intervet International B.V. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
CN102319210B (zh) * 2011-09-29 2013-05-01 武汉回盛生物科技有限公司 一种兽用长效硫酸头孢喹肟注射液及其制备方法
CN104546703B (zh) * 2013-12-10 2017-06-23 中国农业科学院饲料研究所 一种奶牛泌乳期用硫酸头孢喹肟***注入剂及其制备方法
CN104000783B (zh) * 2014-05-14 2017-12-05 河南牧翔动物药业有限公司 头孢喹肟脂质体
CN104873462B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种奶牛干乳期用硫酸头孢喹肟***注入剂及其制备方法
CN107157927A (zh) * 2017-05-31 2017-09-15 合肥中龙神力动物药业有限公司 动物用硫酸头孢喹肟注射液及其制备方法
CN109044970A (zh) * 2018-11-08 2018-12-21 遂宁市中通实业集团动物药业有限公司 一种硫酸头孢喹肟注射液及其制备方法
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺
CN113952298B (zh) * 2021-12-08 2023-02-17 江苏农牧科技职业学院 硫酸头孢喹肟纳米混悬液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920819A (en) * 1974-12-02 1975-11-18 Lilly Co Eli Nonaqueous vehicle for oral pharmaceutical suspensions
IL59948A0 (en) * 1979-05-21 1980-06-30 Rech Applications Therap Penicillanic acid derivatives,their production and pharmaceutical compositions containing them
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
GB8531609D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Compounds
JP3022692B2 (ja) * 1992-10-13 2000-03-21 三菱マテリアル株式会社 リーク検査装置
GB9306106D0 (en) * 1993-03-24 1993-05-12 Norbrook Lab Ltd Sustained release veterinary composition
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
GB9907916D0 (en) * 1999-04-07 1999-06-02 Takeda Chemical Industries Ltd Long-acting antibacterial composition
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle

Also Published As

Publication number Publication date
EP1558263B1 (en) 2006-05-31
PL376840A1 (pl) 2006-01-09
CN1705483A (zh) 2005-12-07
WO2004037265A1 (en) 2004-05-06
ATE327759T1 (de) 2006-06-15
NZ539478A (en) 2006-05-26
EP1558263A1 (en) 2005-08-03
CN1326526C (zh) 2007-07-18
JP2006510607A (ja) 2006-03-30
DE60305728T2 (de) 2006-10-12
ZA200502956B (en) 2006-03-29
AR041713A1 (es) 2005-05-26
NO20051654L (no) 2005-05-24
MXPA05004219A (es) 2005-06-08
CA2501395C (en) 2011-05-24
PL208585B1 (pl) 2011-05-31
CO5700769A2 (es) 2006-11-30
AU2003279302A1 (en) 2004-05-13
AU2003279302B2 (en) 2008-10-16
BR0315513A (pt) 2005-08-23
JP4584715B2 (ja) 2010-11-24
BRPI0315513B1 (pt) 2017-11-28
ES2265590T3 (es) 2007-02-16
DE60305728D1 (de) 2006-07-06
NO334158B1 (no) 2013-12-23
CA2501395A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
FI20011478A0 (fi) Farmaseuttinen koostumus
DE60325255D1 (de) Duftzusammensetzung
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
PT1501534E (pt) Formulacoes farmaceuticas
DK3536344T3 (da) Superfin formoterolformulering
AU2003291103A8 (en) Pharmaceutical composition
DE10393374D2 (de) Zusammensetzung
SE0500163L (sv) Sammansättning
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
DK1587478T3 (da) Farmaceutisk sammensætning
AU2003250372A8 (en) Pharmaceutical composition
EE200300589A (et) Ravimkoostised
DK1561472T3 (da) Faststofsammensætning
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
FI20022128A (fi) Farmaseuttinen koostumus
DE60326900D1 (de) Duftstoff-Zusammensetzung
IS7581A (is) Lyfjasamsetning
NO20044140D0 (no) New Composition
NO20044164L (no) Farmasoytiske sammensetninger
DOP2002000508A (es) Composición farmaceutica
ITMI20020926A0 (it) Composizioni farmaceutiche riepitelizzanti
GB0217703D0 (en) Pharmaceutical composition
FI5468U1 (fi) Farmaseuttinen koostumus